Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 912 to 961 of 6456 in total
Value Type: Measured
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 456\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 398.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 883\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 457\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 23 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-23kd) (ci-23kd) (tyky subunit). [source:swissprot;acc:o00217]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5610.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14731\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm4 (glycine-rich protein) (grp). [source:swissprot;acc:q9y4z0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4620.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5501.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 881.18\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 458\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent elongation of very long chain fatty acids protein 1 (cgi-88). [source:swissprot;acc:q9bw60]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4890.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5610.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14731\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent grb2-related adaptor protein. [source:swissprot;acc:q13588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5986.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6865.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 879.03\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 459\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent myc proto-oncogene protein (c-myc). [source:swissprot;acc:p01106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4892.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5611.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14704\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent pre-mrna splicing factor prp17 (hprp17) (eh-binding protein 3) (ehb3). [source:swissprot;acc:o60508]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5082.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5959.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 877.33\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 460\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 1 (transducin beta chain 1). [source:swissprot;acc:p04901]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 1931.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1057.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 873.95\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 3790.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4346.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14693\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 461\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent grb2-related adaptor protein. [source:swissprot;acc:q13588]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5986.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6865.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14683\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent presenilin 2 (ps-2) (stm-2) (e5-1) (ad3lp) (ad5). [source:swissprot;acc:p49810]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2353.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3225.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 872.02\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 462\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11383.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 9926.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14674\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2353.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3225.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 872.02\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 463\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3720.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4264.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.1463\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent f-box protein fbw7 isoform 2; archipelago, drosophila, homolog of; f-box protein fbw7; f-box protein sel-10; homolog of c elegans sel-10. [source:refseq;acc:nm\_018315]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 2353.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 3225.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 872.02\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 464\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cullin homolog 2 (cul-2). [source:swissprot;acc:q13617]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4858.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5568.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.1461\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 465\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent presenilin 1 (ps-1) (s182 protein). [source:swissprot;acc:p49768]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2353.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3225.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 872.02\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transcription factor e2f1 (e2f-1) (retinoblastoma binding protein 3) (rbbp-3) (prb-binding protein e2f-1) (pbr3) (retinoblastoma-associated protein 1) (rbap-1). [source:swissprot;acc:q01094]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3847.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4409.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14605\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 466\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2353.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3225.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 872.02\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transcription factor e2f2 (e2f-2). [source:swissprot;acc:q14209]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3847.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4409.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14605\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 467\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein beta subunit 4 (transducin beta chain 4). [source:swissprot;acc:q9hav0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1926.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1056.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 870.67\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent metastasis-associated protein mta1. [source:swissprot;acc:q13330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 4864.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5573.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14583\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 468\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 4869.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5578.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14558\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 e1 (ec 6.3.2.19) (ubiquitin-protein ligase e1) (ubiquitin carrier protein e1) (ubch6). [source:swissprot;acc:p51965]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11143.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 10276.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 867.2\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 469\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent proliferating-cell nucleolar antigen p120 (proliferation-associated nucleolar protein p120). [source:swissprot;acc:p46087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3831.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4388.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14554\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2e 3; ubiquitin carrier protein; ubiquitin-protein ligase. [source:refseq;acc:nm\_006357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11143.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 10276.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 867.2\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 470\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent block of proliferation 1. [source:swissprot;acc:q14137]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3796.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4348.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.1455\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5367.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6233.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 866.08\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 471\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 12 (ec 2.7.1.37) (extracellular signal-regulated kinase 6) (erk-6) (erk5) (stress-activated protein kinase-3) (mitogen-activated protein kinase p38 gamma) (map kinase p38 gamma). [source:swissprot;acc:p53778]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5980.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6843.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 863.33\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 472\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5246.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6109.31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 863.3\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sphingosine kinase 1 (ec 2.7.1.-) (sk 1) (spk 1). [source:swissprot;acc:q9nya1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 473\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5979.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6842.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 862.83\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent udp-n-acetylglucosamine--dolichyl-phosphate n- acetylglucosaminephosphotransferase (ec 2.7.8.15) (gpt) (g1pt) (n-acetylglucosamine-1-phosphate transferase) (glcnac-1-p transferase). [source:swissprot;acc:q9h3h5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 474\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5979.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6842.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 862.82\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rho-gtpase-activating protein 7 (rho-type gtpase-activating protein 7) (deleted in liver cancer 1 protein) (dlc-1) (hp protein) (star-related lipid transfer protein 12) (stard12) (start domain-containing protein 12). [source:swissprot;acc:q96qb1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 475\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent e2a-pbx1-associated protein; putative 47 kda protein. [source:refseq;acc:nm\_020140]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5979.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6842.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 862.79\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 476\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5067.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5926.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 859.44\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 477\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5926.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 859.17\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 478\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5066.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5926.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 859.11\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 479\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein l24-like; 60s ribosomal protein l30 isolog; my024 protein; homolog of yeast ribosomal like protein 24. [source:refseq;acc:nm\_016304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7170.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 8029.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 858.81\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 480\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5066.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5925.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 858.45\vspace{3pt}}\\\cline{1-2}\cline{4-6} \parbox{\wcA}{\vspace{3pt}\noindent 481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5493.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6350.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 857.09\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/